Kintor Pharma Confirms Stable Share Capital and Adequate Public Float in September Update

Bulletin Express

Oct 02

Kintor Pharmaceutical Limited reported no changes in its share structure for the month ended 30 September 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing Limited on 2 October 2026.

The company’s authorised share capital remained unchanged at 700.00 million ordinary shares with a par value of USD 0.0001 each, equivalent to total authorised capital of USD 70,000. Issued share capital also stayed flat at 498.66 million ordinary shares, and the issuer held no treasury shares at month-end.

Kintor confirmed compliance with Hong Kong’s minimum public-float requirement of 25%, indicating sufficient free-float liquidity in its share register. The filing records no movements in options, warrants, convertibles, or other share-related instruments during the period.

All requisite confirmations under Main Board Rule 13.25C were provided by Chairman and CEO Youzhi Tong, affirming regulatory compliance across capital-market activities for the month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/news/1159594369"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1159594369\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1159594369?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-02 13:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159594369","market":"us","top_or_hot":-1,"title":"Kintor Pharma Confirms Stable Share Capital and Adequate Public Float in September Update","media":"Bulletin Express","content":"<p>Kintor Pharmaceutical Limited reported no changes in its share structure for the month ended 30 September 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing Limited on 2 October 2026.</p>\n<p>The company’s authorised share capital remained unchanged at 700.00 million ordinary shares with a par value of USD 0.0001 each, equivalent to total authorised capital of USD 70,000. Issued share capital also stayed flat at 498.66 million ordinary shares, and the issuer held no treasury shares at month-end.</p>\n<p>Kintor confirmed compliance with Hong Kong’s minimum public-float requirement of 25%, indicating sufficient free-float liquidity in its share register. The filing records no movements in options, warrants, convertibles, or other share-related instruments during the period.</p>\n<p>All requisite confirmations under Main Board Rule 13.25C were provided by Chairman and CEO Youzhi Tong, affirming regulatory compliance across capital-market activities for the month.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kintor Pharma Confirms Stable Share Capital and Adequate Public Float in September Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKintor Pharma Confirms Stable Share Capital and Adequate Public Float in September Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-10-02 13:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Kintor Pharmaceutical Limited reported no changes in its share structure for the month ended 30 September 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing Limited on 2 October 2026.</p>\n<p>The company’s authorised share capital remained unchanged at 700.00 million ordinary shares with a par value of USD 0.0001 each, equivalent to total authorised capital of USD 70,000. Issued share capital also stayed flat at 498.66 million ordinary shares, and the issuer held no treasury shares at month-end.</p>\n<p>Kintor confirmed compliance with Hong Kong’s minimum public-float requirement of 25%, indicating sufficient free-float liquidity in its share register. The filing records no movements in options, warrants, convertibles, or other share-related instruments during the period.</p>\n<p>All requisite confirmations under Main Board Rule 13.25C were provided by Chairman and CEO Youzhi Tong, affirming regulatory compliance across capital-market activities for the month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09939","symbol_name":"开拓药业-B","start_time":0,"source_url":"","article_id":"1159594369","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159594369","pubTimestamp":1790919709,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Kintor Pharmaceutical Limited reported no changes in its share structure for the month ended 30 September 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09939":"开拓药业-B"},"translate_title":"开拓医药在 9 月份更新中确认稳定的股本和充足的公众持股量","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09939":1},"content_text":"Kintor Pharmaceutical Limited reported no changes in its share structure for the month ended 30 September 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing Limited on 2 October 2026.\nThe company’s authorised share capital remained unchanged at 700.00 million ordinary shares with a par value of USD 0.0001 each, equivalent to total authorised capital of USD 70,000. Issued share capital also stayed flat at 498.66 million ordinary shares, and the issuer held no treasury shares at month-end.\nKintor confirmed compliance with Hong Kong’s minimum public-float requirement of 25%, indicating sufficient free-float liquidity in its share register. The filing records no movements in options, warrants, convertibles, or other share-related instruments during the period.\nAll requisite confirmations under Main Board Rule 13.25C were provided by Chairman and CEO Youzhi Tong, affirming regulatory compliance across capital-market activities for the month.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}